{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:49:53Z","timestamp":1782229793546,"version":"3.54.5"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic neuroendocrine tumors (PanNETs) are rare neoplasms belonging to the broader group of neuroendocrine neoplasms. Epidemiological evidence indicates that visceral obesity is associated with both an increased incidence of PanNETs and unfavorable clinicopathological features. However, the mechanisms underlying adipocyte\u2013PanNETs interactions remain poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Here, we investigated the crosstalk between adipocytes and PanNET cells (BON-1 and QGP-1 cell lines) using indirect co-culture systems and conditioned media derived from differentiated 3T3\u2013L1 adipocytes or PanNET cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our results demonstrate that PanNET cells induce adipocyte reprogramming toward a cancer-associated adipocyte (CAA) phenotype, characterized by lipid depletion and downregulation of adipogenic markers, including\n                      <jats:italic>Pparg, Fabp4, Hsl<\/jats:italic>\n                      , and\n                      <jats:italic>Atgl<\/jats:italic>\n                      . We identified PanNET-derived interleukin-1\u03b2 (IL-1\u03b2) as a key driver of adipocyte conversion into CAAs. This process was accompanied by increased secretion of the chemokine CXCL12 from CAAs, which in turn appeared to enhance PanNET cell proliferation and IL-1\u03b2 release, thereby establishing a positive bidirectional crosstalk consistent with a feedback-like mechanism between CXCL12 and IL-1\u03b2 in CAAs and PanNET cells, respectively. Indeed, pharmacological disruption of this axis using AMD3100, a CXCR4 antagonist, significantly reduced both IL-1\u03b2 and CXCL12 secretion, prevented adipocyte reprogramming, and suppressed tumor cell proliferation. Comparable effects were observed following incubation of PanNET\u2013adipocyte co-cultures with canakinumab, an IL-1\u03b2 pathway inhibitor.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Collectively, these findings identify IL-1\u03b2 and CXCL12 as potential critical mediators of the inflammatory crosstalk between adipocytes and PanNET cells. Targeting this signalling axis may therefore represent a promising therapeutic strategy for PanNETs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08428-z","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:42:56Z","timestamp":1781790176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IL-1\u03b2\/CXCL12 signalling orchestrates adipocyte\u2013pancreatic neuroendocrine tumor crosstalk"],"prefix":"10.1186","volume":"24","author":[{"given":"Monica","family":"Oldani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa Stellaria","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germano","family":"Gaudenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Rybinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Carra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Massardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Caraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Persani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"2","key":"8428_CR1","doi-asserted-by":"publisher","first-page":"188640","DOI":"10.1016\/j.bbcan.2021.188640","volume":"1876","author":"ESA Egal","year":"2021","unstructured":"Egal ESA, Jacenik D, Soares HP, Beswick EJ. Translational challenges in pancreatic neuroendocrine tumor immunotherapy. Biochim et Biophys Acta (BBA) - Rev Cancer. 2021 Dec;1876(2):188640. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188640","journal-title":"Biochim et Biophys Acta (BBA) - Rev Cancer"},{"issue":"2","key":"8428_CR2","doi-asserted-by":"publisher","first-page":"107265","DOI":"10.4291\/wjgp.v16.i2.107265","volume":"16","author":"N Rikhraj","year":"2025","unstructured":"Rikhraj N, Fernandez CJ, Ganakumar V, Pappachan JM. Pancreatic neuroendocrine tumors: a case-based evidence review. World J Gastrointest Pathophysiol. 2025 Jun 22;16(2):107265. https:\/\/doi.org\/10.4291\/wjgp.v16.i2.107265","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"8","key":"8428_CR3","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.3390\/ijms22084041","volume":"22","author":"F Marini","year":"2021","unstructured":"Marini F, Giusti F, Tonelli F, Brandi ML. Pancreatic neuroendocrine neoplasms in multiple Endocrine Neoplasia type 1. IJMS. 2021 Jan;22(8):4041. https:\/\/doi.org\/10.3390\/ijms22084041","journal-title":"IJMS"},{"issue":"10","key":"8428_CR4","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.3390\/jcm14103389","volume":"14","author":"K Bidani","year":"2025","unstructured":"Bidani K, Marinovic AG, Moond V, Harne P, Broder A, Thosani N. Treatment of pancreatic neuroendocrine tumors: beyond traditional Surgery and targeted therapy. J Clin Med. 2025 May 13;14(10):3389","journal-title":"J Clin Med"},{"key":"8428_CR5","doi-asserted-by":"publisher","unstructured":"Alexandraki KI, Spyroglou A, Kykalos S, Daskalakis K, Kyriakopoulos G, Sotiropoulos GC, et al. Changing biological behaviour of NETs during the evolution of the disease: progress on progression. Endocr-Relat Cancer. 2021 Apr 29;28(5):R121\u201340. https:\/\/doi.org\/10.1530\/ERC-20-0473","DOI":"10.1530\/ERC-20-0473"},{"key":"8428_CR6","doi-asserted-by":"publisher","unstructured":"Greenberg J, Limberg J, Verma A, Kim D, Chen X, Lee YJ, et al. Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration. JCI Insight. 2022;7(23):e160130. https:\/\/doi.org\/10.1172\/jci.insight.160130","DOI":"10.1172\/jci.insight.160130"},{"issue":"5","key":"8428_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s12262-015-1360-2","volume":"77","author":"A Paniccia","year":"2015","unstructured":"Paniccia A, Edil BH, Schulick RD. Pancreatic neuroendocrine tumors: an update. Indian J Surg. 2015 Oct;77(5):395\u2013402. https:\/\/doi.org\/10.1007\/s12262-015-1360-2","journal-title":"Indian J Surg"},{"key":"8428_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.semcancer.2025.03.005","volume":"112","author":"M Tacelli","year":"2025","unstructured":"Tacelli M, Gentiluomo M, Biamonte P, Castano JP, Berkovi\u0107 MC, Cives M, et al. Pancreatic neuroendocrine neoplasms (pNens): genetic and environmental biomarkers for risk of occurrence and prognosis. Semin Cancer Biol. 2025 Jul 1;112:112\u201325. https:\/\/doi.org\/10.1016\/j.semcancer.2025.03.005","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"8428_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s40618-021-01715-0","volume":"45","author":"T Feola","year":"2022","unstructured":"Feola T, Puliani G, Sesti F, Modica R, Centello R, Minotta R, et al. Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case\u2013control study. J Endocrinol Invest. 2022 Apr 1;45(4):849\u201357. https:\/\/doi.org\/10.1007\/s40618-021-01715-0","journal-title":"J Endocrinol Invest"},{"key":"8428_CR10","doi-asserted-by":"publisher","unstructured":"Barrea L, Muscogiuri G, Modica R, Altieri B, Pugliese G, Minotta R, et al. Cardio-Metabolic indices and Metabolic syndrome as predictors of clinical severity of gastroenteropancreatic neuroendocrine tumors. Front Endocrinol [Internet]. 2021 Mar 18 [cited 2025 Oct 15];12. Available from: https:\/\/doi.org\/10.3389\/fendo.2021.649496. https:\/\/www.frontiersin.org\/journals\/endocrinology\/articles\/10.3389\/fendo.2021.649496","DOI":"10.3389\/fendo.2021.649496"},{"issue":"20","key":"8428_CR11","doi-asserted-by":"publisher","first-page":"6026","DOI":"10.3390\/jcm11206026","volume":"11","author":"AP Santos","year":"2022","unstructured":"Santos AP, Rodrigues J, Henrique R, Cardoso MH, Monteiro MP. Visceral obesity is associated with shorter progression-free survival in well-differentiated gastro-entero-pancreatic neuroendocrine Neoplasia. JCM. 2022 Oct 12;11(20):6026. https:\/\/doi.org\/10.3390\/jcm11206026","journal-title":"JCM"},{"issue":"11","key":"8428_CR12","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.3390\/cancers17111765","volume":"17","author":"N Otsuka","year":"2025","unstructured":"Otsuka N, Shimamatsu Y, Hakuta R, Takayama Y, Nakai Y. Fatty pancreas: its potential as a risk Factor for pancreatic cancer and clinical implications. Cancers. 2025 Jan;17(11):1765. https:\/\/doi.org\/10.3390\/cancers17111765","journal-title":"Cancers"},{"issue":"5","key":"8428_CR13","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/wjs.12576","volume":"49","author":"Y Fukuda","year":"2025","unstructured":"Fukuda Y, Koga C, Minami S, Ishikawa S, Gakuhara A, Fukuda S, et al. Pancreatic fat accumulation impacts postoperative survival in patients with pancreatic Ductal Adenocarcinoma. World J Surg. 2025;49(5):1327\u201335. https:\/\/doi.org\/10.1002\/wjs.12576","journal-title":"World J Surg"},{"issue":"12","key":"8428_CR14","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.7150\/thno.82911","volume":"13","author":"YC Lin","year":"2023","unstructured":"Lin YC, Hou YC, Wang HC, Shan YS. New insights into the role of adipocytes in pancreatic cancer progression: paving the way towards novel therapeutic targets. Theranostics. 2023;13(12):3925\u201342. https:\/\/doi.org\/10.7150\/thno.82911","journal-title":"Theranostics"},{"issue":"1","key":"8428_CR15","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1038\/s41467-024-48179-3","volume":"15","author":"Y Song","year":"2024","unstructured":"Song Y, Na H, Lee SE, Kim YM, Moon J, Nam TW, et al. Dysfunctional adipocytes promote tumor progression through YAP\/TAZ-dependent cancer-associated adipocyte transformation. Nat Commun. 2024 May 14;15(1):4052. https:\/\/doi.org\/10.1038\/s41467-024-48179-3","journal-title":"Nat Commun"},{"issue":"11","key":"8428_CR16","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011 Nov;17(11):1498\u2013503. https:\/\/doi.org\/10.1038\/nm.2492","journal-title":"Nat Med"},{"issue":"1","key":"8428_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12964-023-01155-8","volume":"21","author":"J Olsza\u0144ska","year":"2023","unstructured":"Olsza\u0144ska J, Pietraszek-Gremplewicz K, Domagalski M, Nowak D. Mutual impact of adipocytes and colorectal cancer cells growing in co-culture conditions. Cell Commun Signal. 2023 Jun 14;21(1):130. https:\/\/doi.org\/10.1186\/s12964-023-01155-8","journal-title":"Cell Commun Signal"},{"issue":"2","key":"8428_CR18","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/cancers15020502","volume":"15","author":"H Na","year":"2023","unstructured":"Na H, Song Y, Lee HW. Emphasis on adipocyte transformation: anti-inflammatory agents to prevent the development of cancer-associated adipocytes. Cancers (Basel). 2023 Jan 13;15(2):502. https:\/\/doi.org\/10.3390\/cancers15020502","journal-title":"Cancers (Basel)"},{"issue":"6","key":"8428_CR19","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3892\/mmr.2021.12506","volume":"24","author":"H Yao","year":"2021","unstructured":"Yao H, He S. Multi\u2011faceted role of cancer\u2011associated adipocytes in the tumor microenvironment (review). Mol Med Rep. 2021 Dec;24(6):866. https:\/\/doi.org\/10.3892\/mmr.2021.12506","journal-title":"Mol Med Rep"},{"issue":"15","key":"8428_CR20","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.3390\/cancers15153756","volume":"15","author":"SD Forsythe","year":"2023","unstructured":"Forsythe SD, Pu T, Andrews SG, Madigan JP, Sadowski SM. Models in pancreatic neuroendocrine neoplasms: current perspectives and future directions. Cancers (Basel). 2023 Jul 25;15(15):3756. https:\/\/doi.org\/10.3390\/cancers15153756","journal-title":"Cancers (Basel)"},{"key":"8428_CR21","doi-asserted-by":"crossref","unstructured":"Ear PH, Marinoni I, Dayton T, Guenter R, Quelle DE, Battistella A, et al. NET models meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations. Endocr Oncol. 2024 Dec 19;4(1):e240055","DOI":"10.1530\/EO-24-0055"},{"issue":"568","key":"8428_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ab.2018.12.020","volume":"568","author":"X Zhao","year":"2019","unstructured":"Zhao X, Hu H, Wang C, Bai L, Wang Y, Wang W, et al. A comparison of methods for effective differentiation of the frozen-thawed 3T3-L1 cells. Analytical Biochem. 2019 Mar;568(568):57\u201364. https:\/\/doi.org\/10.1016\/j.ab.2018.12.020","journal-title":"Analytical Biochem"},{"key":"8428_CR23","doi-asserted-by":"publisher","unstructured":"Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006 Oct 31;7(10):R100. https:\/\/doi.org\/10.1186\/gb-2006-7-10-r100","DOI":"10.1186\/gb-2006-7-10-r100"},{"issue":"1","key":"8428_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12859-021-04344-9","volume":"22","author":"DR Stirling","year":"2021","unstructured":"Stirling DR, Swain-Bowden MJ, Lucas AM, Carpenter AE, Cimini BA, Goodman GA. CellProfiler 4: improvements in speed, utility and usability. BMC Bioinf. 2021 Sep 10;22(1):433. https:\/\/doi.org\/10.1186\/s12859-021-04344-9","journal-title":"BMC Bioinf"},{"issue":"3","key":"8428_CR25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017 Mar 6;214(3):579\u201396. https:\/\/doi.org\/10.1084\/jem.20162024","journal-title":"J Exp Med"},{"issue":"2","key":"8428_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1006\/dbio.2002.0711","volume":"248","author":"ND Lawson","year":"2002","unstructured":"Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol. 2002 Aug 15;248(2):307\u201318. https:\/\/doi.org\/10.1006\/dbio.2002.0711","journal-title":"Dev Biol"},{"issue":"2","key":"8428_CR27","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi G, Oni TE, Spielman B, Hao Y, Elyada E, Park Y, et al. IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic Ductal Adenocarcinoma. Cancer Discov. 2019 Feb 8;9(2):282\u2013301. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0710","journal-title":"Cancer Discov"},{"key":"8428_CR28","doi-asserted-by":"publisher","unstructured":"Sun Y, Zhu D, Wang G, Wang D, Zhou H, Liu X, et al. Pro-inflammatory cytokine IL-1\u03b2 up-regulates CXC chemokine receptor 4 via notch and ERK signaling pathways in tongue squamous cell carcinoma. PLoS One. 2015 Jul 15;10(7):e0132677. https:\/\/doi.org\/10.1371\/journal.pone.0132677","DOI":"10.1371\/journal.pone.0132677"},{"issue":"5","key":"8428_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3727\/096504015X14343704124430","volume":"22","author":"Q Guo","year":"2015","unstructured":"Guo Q, Gao BL, Zhang XJ, Liu GC, Xu F, Fan QY, et al. CXCL12-CXCR4 axis promotes proliferation, migration, invasion, and metastasis of ovarian cancer. Oncol Res. 2015;22(5):247\u201358. https:\/\/doi.org\/10.3727\/096504015X14343704124430","journal-title":"Oncol Res"},{"issue":"1","key":"8428_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3892\/or.2015.3992","volume":"34","author":"YX Liao","year":"2015","unstructured":"Liao YX, Fu ZZ, Zhou CH, Shan LC, Wang ZY, Yin F, et al. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and akt, but not p38 or Erk1\/2, pathways in in vitro and mouse experiments. Oncol Rep. 2015 Jul 1;34(1):33\u201342. https:\/\/doi.org\/10.3892\/or.2015.3992","journal-title":"Oncol Rep"},{"issue":"15","key":"8428_CR31","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.3748\/wjg.14.2308","volume":"14","author":"JK Li","year":"2008","unstructured":"Li JK, Yu L, Shen Y, Zhou LS, Wang YC, Zhang JH. Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro. WJG. 2008 Apr 21;14(15):2308\u201313. https:\/\/doi.org\/10.3748\/wjg.14.2308","journal-title":"WJG"},{"issue":"7","key":"8428_CR32","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.62347\/XZRI9189","volume":"14","author":"Q Cai","year":"2024","unstructured":"Cai Q, Yang J, Shen H, Xu W. Cancer-associated adipocytes in the ovarian cancer microenvironment. Am J Cancer Res. 2024 Jul 15;14(7):3259\u201379","journal-title":"Am J Cancer Res"},{"issue":"18","key":"8428_CR33","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1158\/0008-5472.CAN-13-0530","volume":"73","author":"L Bochet","year":"2013","unstructured":"Bochet L, Lehu\u00e9d\u00e9 C, Dauvillier S, Wang YY, Dirat B, Laurent V, et al. Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer. Cancer Res. 2013 Sep 15;73(18):5657\u201368. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0530","journal-title":"Cancer Res"},{"issue":"11","key":"8428_CR34","doi-asserted-by":"publisher","first-page":"100644","DOI":"10.1016\/j.jlr.2024.100644","volume":"65","author":"M Xue","year":"2024","unstructured":"Xue M, Liao Y, Jiang W. Insights into the molecular changes of adipocyte dedifferentiation and its future research opportunities. J Lipid Res. 2024 Nov;65(11):100644. https:\/\/doi.org\/10.1016\/j.jlr.2024.100644","journal-title":"J Lipid Res"},{"issue":"11","key":"8428_CR35","doi-asserted-by":"publisher","first-page":"111362","DOI":"10.1016\/j.celrep.2022.111362","volume":"40","author":"Q Zhu","year":"2022","unstructured":"Zhu Q, Zhu Y, Hepler C, Zhang Q, Park J, Gliniak C, et al. Adipocyte mesenchymal transition contributes to mammary tumor progression. Cell Rep. 2022 Sep 13;40(11):111362. https:\/\/doi.org\/10.1016\/j.celrep.2022.111362","journal-title":"Cell Rep"},{"issue":"11","key":"8428_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11926-020-00957-w","volume":"22","author":"RG Marangoni","year":"2020","unstructured":"Marangoni RG, Korman B, Varga J. Adipocytic progenitor cells give rise to pathogenic myofibroblasts: adipocyte-to-mesenchymal transition and its emerging role in fibrosis in multiple organs. Curr Rheumatol Rep. 2020 Sep 25;22(11):79. https:\/\/doi.org\/10.1007\/s11926-020-00957-w","journal-title":"Curr Rheumatol Rep"},{"issue":"14","key":"8428_CR37","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.3390\/cancers14143481","volume":"14","author":"T Cuny","year":"2022","unstructured":"Cuny T, van Koetsveld PM, Mondielli G, Dogan F, de Herder WW, Barlier A, et al. Reciprocal interactions between fibroblast and pancreatic neuroendocrine tumor cells: putative impact of the tumor microenvironment. Cancers (Basel). 2022 Jul 18;14(14):3481. https:\/\/doi.org\/10.3390\/cancers14143481","journal-title":"Cancers (Basel)"},{"issue":"15","key":"8428_CR38","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.3390\/cancers14153570","volume":"14","author":"A Papait","year":"2022","unstructured":"Papait A, Romoli J, Stefani FR, Chiodelli P, Montresor MC, Agoni L, et al. Fight the cancer, hit the CAF! Cancers (Basel). 2022 Jul 22;14(15):3570. https:\/\/doi.org\/10.3390\/cancers14153570","journal-title":"Cancers (Basel)"},{"key":"8428_CR39","doi-asserted-by":"publisher","first-page":"743907","DOI":"10.3389\/fcell.2021.743907","volume":"9","author":"P Manoukian","year":"2021","unstructured":"Manoukian P, Bijlsma M, van Laarhoven H. The cellular origins of cancer-associated fibroblasts and their opposing contributions to pancreatic cancer growth. Front Cell Dev Biol. 2021 Sep 27;9:743907. https:\/\/doi.org\/10.3389\/fcell.2021.743907","journal-title":"Front. Cell Dev. Biol"},{"issue":"18","key":"8428_CR40","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.3390\/cancers14184394","volume":"14","author":"C Fotsitzoudis","year":"2022","unstructured":"Fotsitzoudis C, Koulouridi A, Messaritakis I, Konstantinidis T, Gouvas N, Tsiaoussis J, et al. Cancer-associated fibroblasts: the origin, biological characteristics and role in cancer\u2014A glance on colorectal cancer. Cancers. 2022 Jan;14(18):4394. https:\/\/doi.org\/10.3390\/cancers14184394","journal-title":"Cancers"},{"key":"8428_CR41","doi-asserted-by":"publisher","first-page":"102840","DOI":"10.1016\/j.critrevonc.2019.102840","volume":"146","author":"G Vitale","year":"2020","unstructured":"Vitale G, Carra S, Ferra\u00f9 F, Guadagno E, Faggiano A, Colao A. Gastroenteropancreatic neuroendocrine neoplasms and inflammation: a complex cross-talk with relevant clinical implications. Crit Rev Oncol\/Hematol. 2020 Feb 1;146:102840. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.102840","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"2","key":"8428_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000362339","volume":"99","author":"M Cigrovski Berkovic","year":"2014","unstructured":"Cigrovski Berkovic M, Cacev T, Catela Ivkovic T, Zjacic-Rotkvic V, Kapitanovic S. New insights into the role of chronic inflammation and cytokines in the etiopathogenesis of gastroenteropancreatic neuroendocrine tumors. Neuroendocrinology. 2014;99(2):75\u201384. https:\/\/doi.org\/10.1159\/000362339","journal-title":"Neuroendocrinology"},{"issue":"1","key":"8428_CR43","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1038\/s41598-021-84058-3","volume":"11","author":"Y Miyazaki","year":"2021","unstructured":"Miyazaki Y, Oda T, Inagaki Y, Kushige H, Saito Y, Mori N, et al. Adipose-derived mesenchymal stem cells differentiate into heterogeneous cancer-associated fibroblasts in a stroma-rich xenograft model. Sci Rep. 2021 Feb 25;11(1):4690. https:\/\/doi.org\/10.1038\/s41598-021-84058-3","journal-title":"Sci Rep"},{"issue":"11","key":"8428_CR44","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1002\/2211-5463.12976","volume":"10","author":"Y Miyazaki","year":"2020","unstructured":"Miyazaki Y, Oda T, Mori N, Kida YS. Adipose-derived mesenchymal stem cells differentiate into pancreatic cancer-associated fibroblasts in vitro. FEBS Open Bio. 2020;10(11):2268\u201381. https:\/\/doi.org\/10.1002\/2211-5463.12976","journal-title":"FEBS Open Bio"},{"issue":"1","key":"8428_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/cancers15010061","volume":"15","author":"R Peiffer","year":"2022","unstructured":"Peiffer R, Boumahd Y, Gullo C, Crake R, Letellier E, Bellahc\u00e8ne A, et al. Cancer-associated fibroblast diversity shapes tumor metabolism in pancreatic cancer. Cancers (Basel). 2022 Dec 22;15(1):61. https:\/\/doi.org\/10.3390\/cancers15010061","journal-title":"Cancers (Basel)"},{"issue":"1","key":"8428_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40164-025-00607-w","volume":"14","author":"SY Chen","year":"2025","unstructured":"Chen SY, Kung HC, Espinoza B, Washington I, Chen K, Mu K, et al. Distinct response to IL-1\u03b2 blockade in liver- and lung-specific metastasis mouse models of pancreatic cancer with heterogeneous tumor microenvironments. Exp Hematol Oncol. 2025 Feb 13;14(1):13. https:\/\/doi.org\/10.1186\/s40164-025-00607-w","journal-title":"Exp Hematol Oncol"},{"issue":"9","key":"8428_CR47","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.3390\/ijms22094960","volume":"22","author":"NG D\u00edaz-Maroto","year":"2021","unstructured":"D\u00edaz-Maroto NG, Garcia-Vici\u00e9n G, Polcaro G, Ba\u00f1uls M, Albert N, Villanueva A, et al. The blockade of tumoral IL1\u03b2-mediated signaling in normal colonic fibroblasts sensitizes tumor cells to chemotherapy and prevents inflammatory CAF activation. IJMS. 2021 May 7;22(9):4960. https:\/\/doi.org\/10.3390\/ijms22094960","journal-title":"IJMS"},{"issue":"7965","key":"8428_CR48","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"618","author":"A Gavish","year":"2023","unstructured":"Gavish A, Tyler M, Greenwald AC, Hoefflin R, Simkin D, Tschernichovsky R, et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature. 2023 Jun;618(7965):598\u2013606. https:\/\/doi.org\/10.1038\/s41586-023-06130-4","journal-title":"Nature"},{"issue":"7","key":"8428_CR49","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41416-023-02565-8","volume":"130","author":"TY Lai","year":"2024","unstructured":"Lai TY, Chiang TC, Lee CY, Kuo TC, Wu CH, Chen YI, et al. Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors. Br J Cancer. 2024 Apr;130(7):1096\u2013108. https:\/\/doi.org\/10.1038\/s41416-023-02565-8","journal-title":"Br J Cancer"},{"issue":"7","key":"8428_CR50","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1007\/s00125-014-3237-5","volume":"57","author":"D Kim","year":"2014","unstructured":"Kim D, Kim J, Yoon JH, Ghim J, Yea K, Song P, et al. CXCL12 secreted from adipose tissue recruits macrophages and induces insulin resistance in mice. Diabetologia. 2014 Jul;57(7):1456\u201365. https:\/\/doi.org\/10.1007\/s00125-014-3237-5","journal-title":"Diabetologia"},{"issue":"11","key":"8428_CR51","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.7150\/ijbs.82317","volume":"19","author":"Y Yang","year":"2023","unstructured":"Yang Y, Li J, Lei W, Wang H, Ni Y, Liu Y, et al. CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical Applications. Int J Biol Sci. 2023 Jun 26;19(11):3341\u201359. https:\/\/doi.org\/10.7150\/ijbs.82317","journal-title":"Int. J. Biol. Sci"},{"issue":"75","key":"8428_CR52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cytogfr.2023.10.003","volume":"75","author":"DP Anastasiadou","year":"2024","unstructured":"Anastasiadou DP, Quesnel A, Duran CL, Filippou PS, Karagiannis GS. An emerging paradigm of CXCL12 involvement in the metastatic cascade. Cytokine Growth Factor Rev. 2024 Feb;75(75):12\u201330. https:\/\/doi.org\/10.1016\/j.cytogfr.2023.10.003","journal-title":"Cytokine Growth Factor Rev"},{"key":"8428_CR53","doi-asserted-by":"publisher","first-page":"201272","DOI":"10.1016\/j.humgen.2024.201272","volume":"40","author":"P Garg","year":"2024","unstructured":"Garg P, Jallepalli VR, Verma S. Unravelling the CXCL12\/CXCR4 axis in breast cancer: insights into metastasis, microenvironment interactions, and therapeutic opportunities. Hum Gene. 2024 May 1;40:201272. https:\/\/doi.org\/10.1016\/j.humgen.2024.201272","journal-title":"Hum Gene"},{"key":"8428_CR54","doi-asserted-by":"publisher","first-page":"574667","DOI":"10.3389\/fphar.2020.574667","volume":"11","author":"Y Shi","year":"2020","unstructured":"Shi Y, Riese DJ, Shen J. The role of the CXCL12\/CXCR4\/CXCR7 chemokine axis in cancer. Front Pharmacol. 2020 Dec 8;11:574667. https:\/\/doi.org\/10.3389\/fphar.2020.574667","journal-title":"Front Pharmacol"},{"key":"8428_CR55","doi-asserted-by":"publisher","unstructured":"Roberto M, Arrivi G, Di Civita MA, Barchiesi G, Pilozzi E, Marchetti P, et al. The role of CXCL12 axis in pancreatic cancer: new biomarkers and potential targets. Front Oncol [Internet]. 2023 Mar 23 [cited 2025 Oct 15];13. Available from: https:\/\/doi.org\/10.3389\/fonc.2023.1154581. https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2023.1154581","DOI":"10.3389\/fonc.2023.1154581"},{"issue":"13","key":"8428_CR56","first-page":"2842","volume":"20","author":"HQ Zhou","year":"2016","unstructured":"Zhou HQ, Chen QC, Qiu ZT, Tan WL, Mo CQ, Gao SW. Integrative microRNA-mRNA and protein-protein interaction analysis in pancreatic neuroendocrine tumors. Eur Rev Med Pharmacol Sci. 2016 Jul;20(13):2842\u201352","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"8428_CR57","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3390\/cancers16101799","volume":"16","author":"D Sanchis-Pascual","year":"2024","unstructured":"Sanchis-Pascual D, Del Olmo-Garc\u00eda MI, Prado-Wohlwend S, Zac-Romero C, Segura Huerta \u00c1, Hern\u00e1ndez-Gil J, et al. CXCR4: from signaling to clinical Applications in neuroendocrine neoplasms. Cancers (Basel). 2024 May 8;16(10):1799. https:\/\/doi.org\/10.3390\/cancers16101799","journal-title":"Cancers (Basel)"},{"key":"8428_CR58","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.gene.2017.05.009","volume":"625","author":"H Zhou","year":"2017","unstructured":"Zhou H, Chen Q, Tan W, Qiu Z, Li S, Song Y, et al. Integrated clinicopathological features and gene microarray analysis of pancreatic neuroendocrine tumors. Gene. 2017 Aug 20;625:72\u201377. https:\/\/doi.org\/10.1016\/j.gene.2017.05.009","journal-title":"Gene"},{"issue":"14","key":"8428_CR59","doi-asserted-by":"publisher","first-page":"18865","DOI":"10.18632\/oncotarget.7738","volume":"7","author":"L Circelli","year":"2016","unstructured":"Circelli L, Sciammarella C, Guadagno E, Tafuto S, Del Basso de Caro M, Botti G, et al. CXCR4\/CXCL12\/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR. Oncotarget. 2016 Apr 5;7(14):18865\u201375. https:\/\/doi.org\/10.18632\/oncotarget.7738","journal-title":"Oncotarget"},{"issue":"12","key":"8428_CR60","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1158\/1541-7786.MCR-19-0540","volume":"17","author":"MK Herroon","year":"2019","unstructured":"Herroon MK, Diedrich JD, Rajagurubandara E, Martin C, Maddipati K, Kim S, et al. Prostate tumor cell\u2013derived IL1\u03b2 induces an inflammatory phenotype in bone marrow adipocytes and reduces sensitivity to docetaxel via lipolysis-dependent mechanisms. Mol Cancer Res. 2019 Dec;17(12):2508\u201321. https:\/\/doi.org\/10.1158\/1541-7786.MCR-19-0540","journal-title":"Mol Cancer Res"},{"issue":"5","key":"8428_CR61","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/0008-5472.CAN-19-2080","volume":"80","author":"S Das","year":"2020","unstructured":"Das S, Shapiro B, Vucic EA, Vogt S, Bar-Sagi D. Tumor cell\u2013derived IL1\u03b2 promotes desmoplasia and immune suppression in pancreatic cancer. Cancer Res. 2020 Mar 1;80(5):1088\u2013101. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-2080","journal-title":"Cancer Res"},{"issue":"6","key":"8428_CR62","doi-asserted-by":"publisher","first-page":"520","DOI":"10.4251\/wjgo.v8.i6.520","volume":"8","author":"D Karakaxas","year":"2016","unstructured":"Karakaxas D, Sioziou A, Aravantinos G, Coker A, Papanikolaou IS, Liakakos T, et al. Genetic polymorphisms of interleukin 1\u03b2 gene and sporadic pancreatic neuroendocrine tumors susceptibility. WJGO. 2016 Jun 15;8(6):520\u201325. https:\/\/doi.org\/10.4251\/wjgo.v8.i6.520","journal-title":"WJGO"},{"key":"8428_CR63","doi-asserted-by":"publisher","first-page":"204020661982938","DOI":"10.1177\/2040206619829382","volume":"27","author":"E De Clercq","year":"2019","unstructured":"De Clercq E. Mozobil\u00ae (Plerixafor, AMD3100), 10 years after its approval by the US food and drug administration. Antivir Chem Chemother. 2019;27:2040206619829382. https:\/\/doi.org\/10.1177\/2040206619829382","journal-title":"Antivir Chem Chemother"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08428-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08428-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08428-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:30:52Z","timestamp":1782228652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08428-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8428"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08428-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Istituto Auxologico Italiano IRCCS (Approval ID: ZebrAT 2022_03_08_02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the authors declare no Conflict of interest\/Competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"807"}}